MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

Search

Thermo Fisher Scientific Inc

Abrir

SetorSaúde

423.93 0.69

Visão Geral

Variação de preço das ações

24h

Atual

Mín

416.72

Máximo

426.61

Indicadores-chave

By Trading Economics

Rendimento

194M

1.8B

Vendas

795M

11B

P/E

Médio do Setor

25.505

57.333

EPS

6.1

Rendimento de Dividendos

0.4

Margem de lucro

16.007

Funcionários

125,000

EBITDA

377M

3B

Recomendações

By TipRanks

Recomendações

Compra Forte

Previsão para 12 meses

+32.5% upside

Dividendos

By Dow Jones

Rendimento de Dividendos

Médio do Setor

0.40%

2.63%

Próximos Ganhos

23 de jul. de 2025

Próxima data de dividendos

14 de jul. de 2025

Próxima data de ex-dividendo

13 de jun. de 2025

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

-67B

161B

Abertura anterior

423.24

Fecho anterior

423.93

Pontuação Técnica

By Trading Central

Confiança

Bullish Evidence

Thermo Fisher Scientific Inc Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

23 de abr. de 2025, 10:33 UTC

Ganhos

Thermo Fisher 1Q Net, Revenue Up, Costs Stable

25 de fev. de 2025, 14:05 UTC

Aquisições, Fusões, Aquisições de Empresas

Thermo Fisher Scientific to Acquire Solventum's Filtration Unit, Confirming WSJ Report

30 de jan. de 2025, 11:43 UTC

Ganhos

Thermo Fisher Scientific Profit, Revenue Rose in 4Q

23 de abr. de 2025, 10:01 UTC

Ganhos

Thermo Fisher 1Q Adjusted Operating Margin 21.9% >TMO

23 de abr. de 2025, 10:00 UTC

Ganhos

Thermo Fisher 1Q Organic Revenue Rose 1% >TMO

23 de abr. de 2025, 10:00 UTC

Ganhos

Thermo Fisher 1Q EPS $3.98 >TMO

23 de abr. de 2025, 10:00 UTC

Ganhos

Thermo Fisher 1Q Rev $10.36B >TMO

23 de abr. de 2025, 10:00 UTC

Ganhos

Thermo Fisher 1Q Adj EPS $5.15 >TMO

23 de abr. de 2025, 10:00 UTC

Ganhos

Thermo Fisher 1Q Net $1.51B >TMO

25 de fev. de 2025, 14:09 UTC

Aquisições, Fusões, Aquisições de Empresas

Thermo Fisher Strikes Deal for Solventum's Filtration Unit -- WSJ

25 de fev. de 2025, 13:41 UTC

Aquisições, Fusões, Aquisições de Empresas

Solventum: Transaction Is Expected to Be Completed by End of 2025 >SOLV

25 de fev. de 2025, 13:40 UTC

Aquisições, Fusões, Aquisições de Empresas

Solventum Expects Estimated $3.4 B in Net Proceeds >SOLV

25 de fev. de 2025, 13:40 UTC

Aquisições, Fusões, Aquisições de Empresas

Solventum: Deal Strengthens Balance Sheet With Proceeds to Be Used Primarily for Debt Paydown >SOLV

25 de fev. de 2025, 13:40 UTC

Aquisições, Fusões, Aquisições de Empresas

Solventum Expects Deal to Be Neutral to 2025 EPS >SOLV

25 de fev. de 2025, 13:40 UTC

Aquisições, Fusões, Aquisições de Empresas

Solventum: Deal Accelerates Business Transformation and Sharpens Focus on Strategic Areas for Growth

25 de fev. de 2025, 13:39 UTC

Aquisições, Fusões, Aquisições de Empresas

Solventum Announces Sale of Its Purification & Filtration Business to Thermo Fisher Scientific Inc. for $4.1B

25 de fev. de 2025, 13:33 UTC

Aquisições, Fusões, Aquisições de Empresas

Thermo Fisher: Solventum Business Generated About $1 Billion Revenue in 2024 >TMO

25 de fev. de 2025, 13:32 UTC

Aquisições, Fusões, Aquisições de Empresas

Thermo Fisher to Buy Solventum Purification, Filtration Business for About $4.1 Billion Cash >TMO SOLV

25 de fev. de 2025, 13:32 UTC

Aquisições, Fusões, Aquisições de Empresas

Thermo Fisher Scientific To Acquire Solventum's Purification And Filtration Business >TMO

24 de fev. de 2025, 23:03 UTC

Aquisições, Fusões, Aquisições de Empresas

Thermo Fisher Scientific Nears Deal for Solventum's Purification and Filtration Business, Sources Say -- WSJ

24 de fev. de 2025, 23:03 UTC

Principais Notícias
Aquisições, Fusões, Aquisições de Empresas

Thermo Fisher Nears Deal for Solventum Filtration Unit -- WSJ

24 de fev. de 2025, 23:03 UTC

Aquisições, Fusões, Aquisições de Empresas

Deal Could be Announced This Week, Sources Say -- WSJ

24 de fev. de 2025, 23:03 UTC

Aquisições, Fusões, Aquisições de Empresas

Transaction Could Value Solventum Filtration Business Between $3.5B to $4B, Sources Say -- WSJ

30 de jan. de 2025, 11:06 UTC

Ganhos

Thermo Fisher: In a Great Position to Deliver Excellent Performance in 2025 >TMO

30 de jan. de 2025, 11:05 UTC

Ganhos

Thermo Fisher: Will Provide 2025 Fincl Guidance During Earnings Conference Call Thursday Morning >TMO

30 de jan. de 2025, 11:00 UTC

Ganhos

Thermo Fisher 4Q Rev $11.4B >TMO

30 de jan. de 2025, 11:00 UTC

Ganhos

Thermo Fisher 4Q EPS $4.78 >TMO

30 de jan. de 2025, 11:00 UTC

Ganhos

Thermo Fisher 4Q Core Organic Revenue Up 5% >TMO

30 de jan. de 2025, 11:00 UTC

Ganhos

Thermo Fisher 4Q Net $1.83B >TMO

30 de jan. de 2025, 11:00 UTC

Ganhos

Thermo Fisher 4Q Adj EPS $6.10 >TMO

Comparação entre Pares

Variação de preço

Thermo Fisher Scientific Inc Previsão

Preço-alvo

By TipRanks

32.5% parte superior

Previsão para 12 meses

Média 565.32 USD  32.5%

Máximo 650 USD

Mínimo 475 USD

Com base em 19 analistas de Wall Street que oferecem metas de preço de 12 meses para Thermo Fisher Scientific Inc - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Compra Forte

19 ratings

16

Comprar

3

Manter

0

Vender

Pontuação Técnica

By Trading Central

426.51 / 427.44Suporte e Resistência

Curto Prazo

Bullish Evidence

Médio Prazo

No Evidence

Longo Prazo

Bearish Evidence

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre Thermo Fisher Scientific Inc

Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. It has a collaboration agreement with Mainz Biomed N.V. for the development of colorectal cancer screening product. Thermo Fisher Scientific Inc. was founded in 1956 and is headquar